Comparison of Topical Minocycline 4% Gel and Topical Clindamycin 1% Gel in the Treatment of Moderate to Severe Acne Vulgaris: An open label, Randomized Controlled Trial - ToMAc-RC

Dr Sujaya S0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

研究概览

暂无简介。

•1. Participants with moderate-to-severe facial acne, as defined by the Investigatorâ??s Global Assessment (IGA) score of 3 or 4 and lesion counts of 20 to 50 inflammatory lesions (papules, pustules, and nodules), 25 to 100 noninflammatory lesions (open and closed comedones), and no more than 2 nodules.
•2.Either gender (Male or female).
•3. Age 9 years or older.
•4. Ability to understand and the willingness to sign a written informed consent document.

•1. Participants who are pregnant, lactating, or planning to conceive during the study.
•2. Use of oral retinoids or corticosteroids within 12 weeks before randomization, as well as the use of topical retinoids, topical anti-inflammatory drugs and corticosteroids, oral antibiotics, or other systemic acne treatment within 4 weeks before the study.
•3. Any facial skin conditions that would interfere with clinical evaluations, including acne conglobate, acne fulminans, or secondary acne (chloracne or drug-induced acne).

发起方

Dr Sujaya S